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Abstract: Ball-milling is usually used to prepare co-amorphous drug–amino acid (AA) mixtures.
In this study, co-amorphous drug–AA mixtures were produced using spray-drying, a scalable
industrially preferred preparation method. The influence of the solvent type and solvent composition
was investigated. Mixtures of indomethacin (IND) and each of the three AAs arginine, histidine,
and lysine were ball-milled and spray-dried at a 1:1 molar ratio, respectively. Spray-drying was
performed at different solvent ratios in (a) ethanol and water mixtures and (b) acetone and water
mixtures. Different ratios of these solvents were chosen to study the effect of solvent mixtures on
co-amorphous formulation. Residual crystallinity, thermal properties, salt/partial salt formation,
and powder dissolution profiles of the IND–AA mixtures were investigated and compared to pure
crystalline and amorphous IND. It was found that using spray-drying as a preparation method,
all IND–AA mixtures could be successfully converted into the respective co-amorphous forms,
irrespective of the type of solvent used, but depending on the solvent mixture ratios. Both ball-milled
and spray-dried co-amorphous samples showed an enhanced dissolution rate and maintained
supersaturation compared to the crystalline and amorphous IND itself. The spray-dried samples
resulting in co-amorphous samples were stable for at least seven months of storage.
Keywords: co-amorphous; spray-drying; salt formation; process parameter; stability
1. Introduction
Oral pharmaceutical products comprise about 70% of all pharmaceutical products, making oral
administration the most convenient and preferred route of drug delivery [1,2]. Approximately 40–60%
of the currently marketed low-molecular-weight drugs and up to 90% of the current drug development
candidates show poor water solubility [3,4]. Using an amorphous form of the drug is an excellent option
to improve low aqueous solubility, since both the dissolution rates as well as the apparent solubility
are enhanced when converting a crystalline form to its amorphous counterpart [5]. However, a major
challenge with the use of amorphous drugs is their low physical stability, that is, their tendency
to recrystallize upon formulation, storage, or administration [6]. This has led to an urgent need to
increase the understanding of the link between the physicochemical properties of an amorphous drug
and potential interactions with common excipients on the overall physical stability of amorphous
forms. Polymeric glass solutions are frequently investigated systems in this respect; however, usually
a large amount of the polymer is required due to the limited solubility and miscibility of the drug
in the polymer. Certain advantages of using low-molecular-weight excipients in the preparation of
co-amorphous binary systems with the drug have been confirmed through previous studies, such as
a lower amount of excipient, which is required for a stable amorphous system [7,8]. AAs are especially
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promising excipients as they can form strong molecular interactions with drugs, which may play
a crucial role in stabilizing co-amorphous formulations and increasing drug dissolution rates [9–11].
The majority of studies on co-amorphous drug–amino acid mixtures used ball-milling (BM) as
production technique [11–13], which is a difficult process to scale up. In contrast, spray-drying (SD) is
a well-established technique in the food, pharmaceutical, and chemical industries and is more easily
scaled up to an industrial level [14–16]. SD has also been reported as a production technique for polymeric
glass solutions [17] and for co-amorphous drug–drug mixtures [18]. Moreover, SD of AAs as a carrier
for the pulmonary delivery of biopharmaceuticals also has been reported [19]. However, SD has not yet
been extensively used to produce co-amorphous drug–AA mixtures. Recently, co-amorphous drug–AA
mixtures of the drug indomethacin (IND) and three basic AAs, arginine (ARG), histidine (HIS), and lysine
(LYS), respectively, were produced using SD as the manufacturing technique [9].
IND is a nonsteroidal anti-inflammatory drug (NSAID), classified as a Biopharmaceutics
Classification System (BCS) class II drug having low solubility and high permeability. IND has
acidic properties and can exist in several polymorphic solid forms and also as an amorphous solid.
Since IND (log p = 4.05) has hydrophobic properties and the basic AAs (log p < −1.5) are hydrophilic,
Jensen et al. [9] used binary solvents consisting of the organic solvent acetone and water for SD at
fixed solvent ratios. Using spray-drying, IND was successfully converted to an amorphous form
with ARG, HIS, and LYS. In contrast, upon ball-milling, only IND–ARG became fully amorphous.
The intrinsic dissolution experiments of the co-amorphous spray-dried mixtures showed a nearly
200-fold increase for the spray-dried IND–ARG compared with crystalline or amorphous ball-milled
IND. However, no significant increase in intrinsic dissolution was found for SD IND–LYS and SD
IND–HIS. Other researchers have discussed that uneven solvent evaporation could occur when using
acetone–water mixtures as cosolvents [20]. This may create a risk for drug–AA phase separation
leading to a nonhomogeneous SD powder [9]. To further investigate this issue, the current study
uses two different organic solvents for SD: ethanol, which is a polar protic solvent; and acetone,
which is a polar aprotic solvent. Both these organic solvents were used at different ratios with water.
By changing the solvent composition, it is desired to find the applicable formulation parameters under
which IND–AA mixtures turn co-amorphous upon spray-drying. In addition to SD, BM was also used
in this study as a comparative technique for co-amorphous sample preparation.
2. Materials and Methods
2.1. Materials
IND was obtained from Fagron (Copenhagen, Denmark) and the 3 basic AAs (ARG, HIS, and LYS)
were acquired from Sigma-Aldrich Chemie (Steinheim, Germany). All AAs and the drug used in
this study were of reagent grade and used as received. Ethanol and acetone were 99.9% pure (HPLC
grade) and received from Sigma Aldrich (Poole, UK). Water (18.2 MΩ), used as the cosolvent in SD,
was freshly prepared using a MilliQ water system from LabWater (Los Angeles, CA, USA).
2.2. Preparation Methods
2.2.1. Ball-Milling
BM samples were produced as follows: a total mass of 700 mg crystalline IND and AA (ARG, HIS,
and LYS, respectively) at a 1:1 molar ratio was introduced to 25 mL milling jars. Two 12 mm stainless steel
balls were added. The vibrational ball-mill (MixerMill MM400, Retsch GmbH & Co., Haan, Germany)
was placed in a cold room (4 ◦C). Continuous milling was performed at 30 Hz for up to 60 min.
2.2.2. Spray-Drying
IND and each of the AAs were weighed and combined together at a 1:1 molar ratio, respectively.
These mixtures were then dissolved in (i) ethanol and milliQ water; and (ii) acetone and milliQ water,
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each to give 250 mL of final solutions, respectively. The ethanol and water mixtures contained 95%,
90%, 80%, 60%, 40%, 10%, and 5% (v/v) ethanol. The acetone and water mixtures contained 85%,
70%, 55%, 45%, 30%, and 15% (v/v) of acetone. The concentration of IND–AA in the solutions varied
from 1.92 mg/mL to 51.4 mg/mL (see Table 1), depending on the aqueous AA solubility and the
solubility of IND in the organic solvent. SD was performed using a Büchi B-290 spray-dryer (Büchi
Labortechnik AG, Flawil, Switzerland) equipped with an inert loop B-295 (Büchi Labortechnik AG,
Flawil, Switzerland). For the ethanol-water samples, SD conditions were as follows: inlet temperature:
140 ◦C; outlet temperature: 90 ◦C; atomizing air flow rate: 667 L/h; drying air flow (nitrogen): 40 m3/h
and feed flow rate: 9 mL/min. For the acetone-water samples, the inlet temperature was decreased to
135 ◦C and the outlet temperature was 75 ◦C. The outlet temperature was always maintained below
the glass transition temperature of SD IND–AA mixtures.
2.3. Analytical Methods
2.3.1. X-ray Powder Diffraction (XRPD)
All drug–AA mixtures prepared by BM and SD were investigated in triplicates by X-ray powder
diffraction (XRPD) using an X´Pert PANanalytical PRO X-ray diffractometer (PANanalytical, Almelo,
The Netherlands) with Cu kα radiation (1.54187 Å), current: 40 mA and acceleration voltage: 45 kV.
Each of the BM and SD samples was scanned at a scan rate of 0.067◦ 2θ/s and a step size of 0.026◦ 2θ in
the range 2◦ to 35◦ 2θ in reflectance mode. The data collected was analysed using X´Pert PANanalytical
Collector software (PANanalytical, Almelo, The Netherlands).
2.3.2. Modulated Differential Scanning Calorimetry (mDSC)
Thermal analysis was performed using a Discovery DSC (TA Instruments, New Castle, DE, USA).
Each sample weighing approximately 6–8 mg was placed into an aluminium Tzero pan and sealed
with an aluminium Tzero lid. Calibration of temperature and enthalpy was carried out with indium.
A heating rate of 2 ◦C/min was used with amplitude of 0.2120 ◦C and a period of 40 s. Measurements
ranged from −20 ◦C to 180 ◦C. A constant nitrogen flow rate of 50 mL/min was applied during each
measurement. The glass transition temperature (Tg) was found by analyzing the data collected using
Trios software (TA Instruments, New Castle, DE, USA), and reported as the half height of the onset
and end set temperature in the reversing heat flow of the thermograms of three independent samples.
2.3.3. Fourier-Transform Infrared Spectroscopy (FTIR)
Infrared spectra were obtained using a Nicolet 380 FTIR (Thermo Scientific, Madison, WI, USA)
attached with an attenuated total reflectance accessory (ATR, Smart iTR, Thermo Scientific, Madison,
WI, USA). Spectra were collected in triplicates over a range of 4000–400 cm−1 (64 scans, resolution
4 cm−1). The spectral region from 1500 to 1700 cm−1 was investigated for analysis of salt formation
with ThermoScientific OMNIC software (version 8.1.11).
2.3.4. Powder Dissolution
A USP type II apparatus (Erweka DT600 dissolution tester, Erweka GmbH, Heusenstamm, Germany)
was used to perform powder dissolution of selected co-amorphous formulations. 650 mg samples were
added to 100 mL USP 0.1 M phosphate buffer of pH 7.2 as the dissolution medium. Three replicates
were conducted for each sample in a modified, custom-made set-up using 250 mL vessels, with rotating
minipaddles at 100 rpm and a temperature of 37 ◦C. Being a down-scaled version of the USP type II
apparatus, the minivessel and paddles showed essentially similar hydrodynamics when compared to the
standard USP type II apparatus [21]. 1 mL of sample was collected after 10, 30, 60, 120, and 180 min of
dissolution testing, using a 0.22-µm latex-free syringe filter (Qmax, Frisinette APS, Knebal, Denmark) and
replaced with 1 mL buffer solution. The concentration of IND in the buffer was measured in triplicates by
a UV spectrophotometer Evolution 300 (Thermo Scientific, Cambridge, UK) at 264 nm.
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2.4. Storage
All samples were stored in a desiccator over silica gel (5.4% relative humidity) at room temperature
and a physical stability study was performed for all SD samples. A few mg from each sample was taken
out and analyzed by XRPD at day 0 and once every month after that. The remaining samples were
placed back into the desiccator for further stability studies and the measured samples were discarded.
3. Results and Discussion
3.1. Preparation of Co-Amorphous Formulations
IND–AA mixtures (IND–ARG, IND–HIS, and IND–LYS) at a 1:1 molar ratio were investigated for
their ability to form co-amorphous systems using both BM and SD, where the emerging technique of SD
was compared to the established technique of BM. BM was performed first to investigate the formation
of a co-amorphous system without the use of solvents. Figure 1 shows the XRPD diffractograms of the
crystalline raw materials and the mixtures after BM. Only the IND–ARG system was fully amorphous
after 60 min of BM, whereas IND–LYS and IND–HIS showed residual crystallinity of the respective
amino acids. LYS reflections were observed in BM IND–LYS at 10.1◦ 2θ, 18.6◦ 2θ, 19.7◦ 2θ, 20.6◦ 2θ,
21.2◦ 2θ, 23◦ 2θ, 25◦ 2θ, and 27◦ 2θ. On the other hand, IND–HIS showed HIS reflections at 9.4◦ 2θ,
15◦ 2θ, 19◦ 2θ, and 24◦ 2θ, with some overlapping reflections of HIS/IND (around 21◦ 2θ) and IND
reflections at 17◦ 2θ and 30◦ 2θ after 60 min of BM.
Due to this remaining crystallinity, the glass transition temperatures (Tgs) observed for
IND–LYS and IND–HIS do not necessarily represent the systems to be at the 1:1 molar ratio.
However, the experimentally determined Tgs of the BM IND–AAs (110.1 ◦C, 92.7 ◦C, and 94.5 ◦C for
IND–ARG, IND–HIS, and IND–LYS, respectively) were applicable to form the basis for the design
of the SD process, where the outlet temperature has to be maintained below the Tg in order to avoid
recrystallization during the process.
Figure 1. X-ray powder diffraction (XRPD) diffractograms of (a) crystalline (C) lysine (LYS), histidine
(HIS), arginine (ARG), and indomethacin (IND). (b) Mixtures of IND–LYS, IND–HIS, and IND–ARG
prepared by ball-milling (BM) for 60 min.
Figure 2 shows the XRPD diffractograms of SD IND–AA mixtures at various solvent compositions.
SD IND–ARG was found to be co-amorphous for all solvent mixtures used. In contrast to the
ball-milling results, amorphous mixtures were also achieved for the majority of solvent mixtures
in SD IND–HIS and SD IND–LYS. However, some limitations were observed for these systems upon
spray-drying, presumably due to kinetic changes in the solvent composition during processing. Using
acetone–water blends, IND–HIS and IND–LYS show crystallization of the respective amino acids HIS
and LYS when the acetone concentration is higher than 85% and 70%, respectively, probably due to the
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low solubility of the AAs in the solvent, due to the high proportion of acetone. Vice versa, systems
with an acetone concentration less than 30% show the presence of crystalline IND in SD IND–HIS and
SD IND–LYS (Figure 2). This suggests that the drug–AA systems crystallize differently at different
organic solvent–water mixture concentrations. Similar findings were seen for the ethanol–water
mixtures for SD IND–HIS and SD IND–LYS when the ethanol content was below 20% or above 90%.
Thus, both SD IND–HIS and SD IND–LYS require a solvent composition in a certain range to achieve
an amorphous product. This means that IND requires a specific minimum concentration of organic
solvent (acetone/ethanol), and HIS and LYS require a specific minimum water concentration to form
an amorphous product. This makes the solvent fraction an important parameter in co-amorphous
formulation, and not just the solvent type (protic/aprotic).
Figure 2. XRPD diffractograms of indomethacin–arginine (IND–ARG), IND–histidine (IND–HIS) and
IND–lysine (IND–LYS) mixtures prepared by spray-drying (SD). Organic solvent denoted in percentage
(%) is acetone (AC) in (a,c,e); and ethanol (EtOH) in (b,d,f).
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3.2. Thermal Analysis of Co-Amorphous Systems
The Tg of an amorphous homogeneous glass solution can be calculated theoretically using the
Gordon–Taylor (GT) equation (Equation (1)), where Tg1 and Tg2 are the glass transition temperatures of
the different components in the drug–AA mixtures and w1 and w2 are the weight fractions of the drug
and AA. Interactions between two components in a binary mixture are not considered in the GT equation.
Tg = (w1 · Tg1 + K w2 · Tg2)/(w1 + Kw2) (1)
The constant K is calculated by Equation (2):
K = (Tg1 · ρ1)/(Tg2 · ρ2) (2)
where ρ1, ρ2 are the densities of the compounds [22]. The values were calculated using Table 2.
Table 1 summarizes the results of the XRPD, DSC, and FTIR measurements for the various
formulations and solvent compositions. It can be seen from Table 1 and Section 3.1 that upon
using different organic solvent concentrations, the resulting IND–AAs show differences in product
characteristics, such as the Tg. This is in line with the finding of Patterson et al. [23] that IND-based
products showed differences in characteristics such as Tg and dissolution rate when produced by different
manufacturing techniques. As shown by the XRPD analysis, all investigated SD IND–ARG mixtures
became amorphous, irrespective of solvent concentration or the solvent itself. In contrast, SD IND–LYS
and SD IND–HIS only became fully amorphous depending on the solvent composition (Figure 2).
Table 1. Characterization of indomethacin–amino acid (IND–AA) mixtures prepared by spray-drying.
IND–AA
Mixtures Solvent Mixture
ORGANIC Solvent Content
%:Water Content % (v/v)
Concentration (mg/mL) in
the Spray-Drying Solution XRPD
Tg by mDSC
(◦C)
Tg by GT
(◦C) FTIR
IND–ARG Acetone + water 85:15 51.4 A 115.6 ± 0.6 41.3 SF
70:30 38.7 A 115.4 ± 1.2 41.3 SF
55:45 14 A 116.4 ± 0.4 41.3 SF
45:55 9 A 116.7 ± 0.7 41.3 SF
30:70 7 A 116.5 ± 0.6 41.3 SF
15:85 4.8 A 115.7 ± 0.5 41.3 SF
IND–HIS Acetone + water 85:15 9 C - - PoNSF
70:30 12 A 99.8 ± 0.4 35.9 PoNSF
55:45 14.8 A 101.9 ± 0.7 35.9 PoNSF
45:55 18 A 95.1 ± 1.3 35.9 PoNSF
30:70 21 A D: 49.6 ± 1.4,110.8 ± 0.4 - PoNSF
15:85 25 C - - PoNSF
IND–LYS Acetone + water 85:15 1.92 C - - SF
70:30 12 A 98.1 ± 1.3 41.8 SF
55:45 20 A 99.1 ± 1.6 41.8 SF
45:55 25 A 97.5 ± 0.8 41.8 SF
30:70 29 A 96.8 ± 0.6 41.8 SF
15:85 36 C - 41.8 SF
IND–ARG Ethanol + water 95:05 15 A 116.6 ± 1.4 41.3 SF
90:10 12 A 114.8 ± 1.8 41.3 SF
80:20 9 A 114.2 ± 1.2 41.3 SF
60:40 7 A 118.1 ± 0.7 41.3 SF
40:60 5 A 116.7 ± 1.2 41.3 SF
20:80 3 A 116.1 ± 0.8 41.3 SF
10:90 2 A 115.9 ± 0.4 41.3 SF
05:95 1.2 A 115.4 ± 0.6 41.3 SF
IND–HIS Ethanol + water 95:05 13.5 C - - PoNSF
90:10 13 C - - PoNSF
80:20 14.5 A 96.7 ± 0.4 35.9 PoNSF
60:40 15 A 98.6 ± 0.6 35.9 PoNSF
40:60 17.5 A 97.8± 0.5 35.9 PoNSF
20:80 19 C - - PoNSF
10:90 20.5 C - - PoNSF
05:95 21 C - - PoNSF
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Table 1. Cont.
IND–AA
Mixtures Solvent Mixture
ORGANIC Solvent Content
%:Water Content % (v/v)
Concentration (mg/mL) in
the Spray-Drying Solution XRPD
Tg by mDSC
(◦C)
Tg by GT
(◦C) FTIR
IND–LYS Ethanol + water 95:05 1.5 C - - SF
90:10 2.8 C - - SF
80:20 7 A 100.8 ± 1.2 41.8 SF
60:40 8.5 A 98.9 ± 0.8 41.8 SF
40:60 10 A 102.1 ± 0.7 41.8 SF
20:80 11.2 A D: 39.6 ± 0.4,97.5 ± 1.2 - SF
10:90 11.8 C - - SF
05:95 13 C - - SF
mDSC: modulated differential scanning calorimetry, GT: Gordon–Taylor equation, FTIR: Fourier-transform infrared
spectroscopy, ARG: Arginine, HIS: Histidine, LYS: Lysine, A: Amorphous, C: Crystalline, D: Double (two) Tgs,
SF: salt formation, PoNSF: partial or no salt formation.
The obtained Tgs of the respective samples in the current study correspond well to the Tgs
obtained in an earlier study by Jensen et al. who found the Tgs of co-amorphous SD IND–ARG,
SD IND–HIS, and SD IND–LYS to be 114.4 ◦C, 98.0 ◦C, and 99.5 ◦C, respectively [9]. The noticeable
increase in Tg (of around 4–6 ◦C; see Table 1 and Figure 3) when produced through SD compared
to BM (Section 3.1) points to an increased molecular interaction between the drug and AA upon
SD. All samples besides IND–HIS spray dried from 30% acetone and IND–LYS spray dried from
20% ethanol show a single Tg value. The presence of two Tgs for the abovementioned systems is
attributed to phase separation. In both cases, the second Tg, which is also the higher Tg, corresponds
to the respective co-amorphous systems. For SD IND–HIS, the first Tg is attributed to an IND-rich
co-amorphous system, whereas for SD IND–LYS, it corresponds to the Tg of the pure IND itself.
This confirms that both SD IND–HIS and SD IND–LYS are dependent on the solvent composition
and thus require the correct amount of solvent fraction in order to obtain a completely co-amorphous
system with a single Tg. The Tg values for all IND–AA mixtures were considerably higher when
compared to the Tg of the pure drug itself, which was reported to be 36.7 (±0.8) ◦C [7]. Also, the Tgs
of pure amorphous ARG, HIS, and LYS which were reported as 55 ◦C, 37.0 (±5.6) ◦C, and 68 (± 2.1)
◦C [24,25], respectively, are significantly lower than the Tgs of the co-amorphous systems reported in
this study. Thus, all mixtures show a strong positive deviation from the calculated Tg according to the
Gordon–Taylor equation, indicating strong molecular interactions between IND and the amino acids.
This is presumably due to salt formation and will be more closely investigated in the following section.
Table 2. Density, molar mass, solubility, and pKa of the drug and AAs used in this study [9]. a Solubility
of indomethacin based on phosphate buffer pH 7.2 [26].
Chemical Substances Density (g/cm3) Molar Mass (g/mol) Water Solubility (mg/mL) pKa
Indomethacin 1.379 357.79 0.75 a 4.5
Arginine 1.325 174.2 50 12.48
Histidine 1.412 155.15 41.6 6.04
Lysine 1.237 146.2 100 10.79
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Figure 3. Glass transition temperature (Tg) of indomethacin–arginine (IND–ARG), IND–histidine
(IND–HIS), and IND–lysine (IND–LYS) prepared by different preparation methods. The horizontal lines
in each graph indicate the Tg measured from ball-milled (BM) samples and theoretical Tg calculated
using the Gordon–Taylor equation (GT), respectively. Vertical bars represent Tg values of spray-dried
co-amorphous samples where the organic solvent denoted in percentage (%) is acetone (AC) in (a,c,e);
and ethanol (EtOH) in (b,d,f).
3.3. Investigation of Molecular Interactions by FTIR Spectroscopy
Jensen et al. [10] reported FTIR data for the SD IND–AA mixtures used in this study and found
complete salt formation only in case of IND–ARG and IND–LYS. Likewise, the influence of the solvent
composition on the molecular arrangement for all spray-dried mixtures (mentioned in Table 1) was
investigated by the use of FTIR spectroscopy. The region between 1500–1750 cm−1 was chosen for
analysis as the vibrational modes of the carboxylic acid group, which is responsible for salt formation,
lie in this range [8]; the occurrence of salt formation versus partial or no salt formation was found to be
independent of the solvent ratio. In this section, two exemplary solvent compositions which resulted
in co-amorphous samples were chosen for a detailed investigation: 55% acetone and 80% ethanol.
In Figure 4, the FTIR spectra of the co-amorphous mixtures are compared to the FTIR spectra of the
amorphous drug itself. Generally, all spectra obtained from co-amorphous mixtures show a strong
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resemblance with the spectrum of amorphous IND, and it can thus be stated that the spectra are
dominated by the vibrations originating from IND. Spectral differences are foremost found in the
region 1660–1750 cm−1, where the symmetric stretch of the carbonyl group from the free carboxylic
acid is located.
Hydrogen-bonded carboxylic acid vibrations at 1710 cm−1 (when spray-dried with acetone–water
mixture) and 1707 cm−1 (when spray-dried with ethanol–water mixture) and the nonhydrogen bonded
acid vibration at 1734 cm−1 disappeared in the case of SD IND–ARG and SD IND–LYS compared to the
spectra of amorphous IND, due to loss of the proton. This suggests ionisation [8,27] and thus salt formation.
In the case of SD IND–HIS, the peak at 1734 cm−1 remained present, whereas the peak at 1710 cm−1
slightly shifted to 1707 cm−1, indicating that no complete salt formation occurred. Thus, the obtained
results are in line with earlier findings [9] and confirm salt formation for IND–ARG and IND–LYS.
The pKa difference plays an important role in the determination of salt formation as a difference of more
than 2 is a preferred scenario for salt formation [28]. In the case of IND and HIS, the pKa difference is only
1.5 and complete salt formation could not be expected, whereas the pKa difference between IND–LYS and
IND–ARG is 6.3 and 8.0, suggesting that complete salt formation can be observed.
Figure 4. FTIR spectra of co-amorphous indomethacin–arginine (IND–ARG), IND–histidine (HIS),
and IND–lysine (LYS) mixtures prepared by spray-drying (SD) with (a) 55% acetone as solvent and (b)
80% ethanol as solvent. For comparison, the FTIR spectrum of amorphous (A) IND is also shown in (b).
3.4. Dissolution Rate
An earlier study on spray-dried IND–AA mixtures [10] found the intrinsic dissolution rate (IDR)
of SD IND–ARG until 20 min to be much higher than that of both crystalline and amorphous IND.
It was also observed that the IDR of SD IND–HIS and SD IND–LYS were similar to each other and
significantly lower than that of SD IND–ARG. Based on these earlier findings and the differences in salt
formation found in this study, one could expect to see varying results for powder dissolution rates and
apparent drug solubility as well. Furthermore, it has been reported that the preparation of amorphous
dispersions by different techniques can have significant effects on dissolution rates [29]. The dissolution
behaviour of ball-milled and exemplary spray-dried co-amorphous samples of IND–ARG, IND–HIS,
and IND–LYS (SD from 70% and 55% acetone concentration, 80% and 40% ethanol concentration) was
investigated (Figure 5). The selection of the solvent mixtures was based on the fact that all IND–AA
formulations became fully co-amorphous upon SD at these solvent ratios. The dissolution study was
carried out at pH 7.2 to ensure complete ionization of IND. The pH of the dissolution media was
measured before and at the end of the dissolution experiment and was found to be unchanged.
Irrespective of the amino acid coformer, solvent type, or solvent ratio used, similar release
profiles from powder dissolution were observed for all co-amorphous mixtures. Neither could a clear
difference be seen between the co-amorphous samples made by the two different preparation methods.
For all co-amorphous samples, the maximum dissolved amount is reached within 10 min, followed
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by a plateau for the measuring duration of 60 min. The pure amorphous IND followed the same
pattern, but reached a lower maximum concentration of dissolved drug. Compared to the reported
equilibrium solubility of crystalline IND in phosphate buffer at pH 7.2 of around 750 µg/mL reported
by Bahl et al. [26], the amorphous IND alone reached a degree of apparent supersaturation (DS) of 2,
whilst the co-amorphous mixtures reached a DS of around 4.5 to 5. The high dissolution rate of both
BM and SD IND–AA mixtures could be due to the ionization between the drug and the amino acids
and the higher water solubility of these amino acids [30]. All the three basic coformers (ARG, HIS,
and LYS) showed similar dissolution rates when mixed with the acidic drug IND, irrespective of their
different water solubilities (Table 2). Further, the addition of the coformer may prevent recrystallization
of the drug, that is, act as a precipitation inhibitor [31].
Figure 5. Powder dissolution curves of amorphous (A) indomethacin (IND), spray-dried IND–amino
acid mixtures from 70% and 55% acetone (AC) concentration and 80% and 40% ethanol (EtOH)
concentration, and ball-milled (BM) IND–amino acid mixtures; for (a) arginine (ARG), (b) histidine
(HIS), and (c) lysine (LYS). Saturation solubility of crystalline IND is around 750 µg/mL [26].
3.5. Physical Stability During Storage
All samples were analyzed by XRPD at regular time intervals in order to determine their physical
stability. Generally, all formed co-amorphous systems were stable for at least eight months of storage,
with few exceptions. As could be expected, all IND–ARG systems remained stable throughout the
study period. Recrystallization of IND was observed in the XRPD diffractograms for SD IND–HIS and
SD IND–LYS spray-dried with 30% and 70% acetone concentrations, respectively; and SD IND–LYS
spray-dried with 20% ethanol concentration (Figure 6). It can be seen from Table 1 that these
formulations were produced under conditions which were on the boundary of solvent compositions
leading to a crystalline product. As ethanol seems to yield stable co-amorphous systems for a larger
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span of solvent ratios and formulations, it may be considered as a slightly better organic solvent for
co-amorphous preparation than acetone.
Figure 6. Stability studies (XRPD diffractograms of spray-dried samples) of indomethacin–arginine
(IND–ARG), IND–histidine (IND–HIS) and IND–lysine (IND–LYS) mixtures after eight months of
storage. Organic solvent denoted in percentage (%) is acetone (AC) in (a,c,e); and ethanol (EtOH) in
(b,d,f). (c,e,f) include diffractograms of SD IND–HIS with 30% acetone, SD IND–LYS with 70% acetone,
and SD IND–LYS with 20% ethanol, respectively. These samples were co-amorphous until storage
month seven.
4. Conclusions
This study shows that, in contrast to ball-milling, IND mixtures could be successfully converted
into co-amorphous forms by spray-drying with the three amino acids used. The solvent ratio (organic
solvent–water) was found to be an important parameter to achieve a co-amorphous formulation.
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Co-amorphous products could be obtained from both acetone and ethanol water mixtures. IND–ARG
always showed a single Tg when spray-dried from organic solvent–water mixtures, irrespective
of solvent type. For IND–LYS and IND–HIS, a single Tg was only observed at intermediate solvent
mixture ratios (30% to 80% organic solvent), while extreme ratios led to products with either crystallised
amino acid or drug. This suggests that phase separation or crystallization can be prevented by
spray-drying IND–AAs at certain solvent mixture fractions. Salt formation was confirmed for both
IND–ARG and IND–LYS by FTIR spectroscopy. All BM and SD IND–AAs showed a strong increase in
dissolution rate compared to the individual crystalline and amorphous drug, including SD IND–HIS,
although no or only partial salt formation was observed in this case. All co-amorphous BM and SD
samples remained supersaturated for up to 60 min. Most of the SD co-amorphous IND–AA mixtures
were found to be stable for more than eight months at room temperature. It can be concluded from this
study that all IND–AA mixtures could be transformed to a co-amorphous form using spray-drying,
depending on the correct choice of the type and the amount of organic solvent.
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